A start-up biotechnology company says it received the okay for its investigational new drug application of an anti-viral drug to treat a whole class of seasonal flu strains.
https://sciencebusiness.technewslit.com/?p=45246
#News #Press #Science #Business #Biotechnology #Virus #InfluenzaA #FDA #SeasonalFlu #AntiViral #StartUp #Entrepreneurs #Preclinical #IND #ClinicalTrial #Regulations #Licensing